The Impact of COVID-19 on Lung Cancer Treatment in Europe

Centerline

Prior to the pandemic, lung cancer was the leading cause of cancer deaths worldwide. Without addressing the impact of COVID-19 on lung cancer services and ensuring long-term resilience, report shows how that trend looks set to increase.

Más información

Putting Patient Safety Front and Center with IDENTIFY

Centerline

As part of its ongoing commitment to Intelligent Cancer Care, Varian combines innovation with advances in patient identification, safety, and motion tracking to offer a comprehensive patient guidance system. The Varian IDENTIFY™ system is incorporated wit...

Más información

Brachytherapy Applicators for Gynecological Treatment: No Longer One-Size-Fits-All

Centerline

In the US alone, more than 110,000 new cases of gynecological cancer are diagnosed each year, with more than 32,000 deaths, according to the American Cancer Society.

Más información

Varian’s Adaptive Intelligence Consortium Amassing Clinical Evidence

Centerline

In April 2019, Varian announced the formation of the Adaptive Intelligence™ Consortium (AIC), a global community of clinicians and scientists from leading cancer clinics working to develop best practices for adaptive radiotherapy based on clinical evidenc...

Más información

HyperArc Proves Itself in Study after Study: A Brief Survey of Recent Literature

Centerline

When a new treatment technology comes on the scene, clinicians naturally want to be assured that it meets or exceeds the performance of established and familiar ones. Since HyperArc® high-definition radiotherapy was introduced at ASTRO in 2016, at least 8...

Más información

HyperArc Helps Community-Based Hospital Radiosurgery Program Succeed in a Highly Competitive Market

Centerline

Varian’s HyperArc® high-definition radiosurgery, delivered on the Edge® platform, is helping the radiosurgery program at Good Samaritan, a 408-bed community hospital in West Islip, NY, succeed in the highly competitive New York City (NYC) area market.

Más información

Is Prostate SBRT a Valid Option? The Evidence is In, and It's Good News

Centerline

After decades of data collected on thousands of patients, evidence points to SBRT as a safe and effective option for the treatment of early- to mid-stage prostate cancer.

Más información

Linac-based SBRT for Prostate: Becoming a Standard Option at UCLA

Centerline

Increasingly, prostate cancer patients at UCLA are choosing SBRT with the support of their urologists due to convenience and efficacy.

Más información

Record Prostate SBRT Treatment Times on Halcyon

Centerline

Northwest Community Healthcare is a community hospital in the Arlington Heights suburbs of Chicago, on the leading edge of radiation treatment. Its Cancer Care Clinic boasts a comprehensive radiation treatment program with multiple treatment modalities.

Más información

IDENTIFY: The Next Generation of SGRT Technology Is Now Available

Centerline

Varian added the IDENTIFY™ system to the company’s product portfolio with an acquisition in August of 2018.

Más información